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Background: The important detection of in-stent restenosis in cardiovascular computed tomography (CT) is still
challenging. The first study assessing the in-vitro stent lumen visualization of the state of the art 256-multislice CT
(256-MSCT), which was performed by our research group, yielded promising results. As the applied technical
approach is not suitable for daily routine, we assessed the capability of the 256-MSCT and its different reconstruction
kernels for the coronary stent lumen visualization employing a clinically applicable technique in a phantom study.
Results: The XCD kernel showed significantly lower artificial lumen narrowing (ALN) values (overall ALN < 40%) than
the other reconstruction kernels (CC, CD, XCB) irrespective of the stent caliber. The ALN of coronary stents with a
diameter >3 mm was significantly lower than of stents with a smaller caliber. The ALN difference between stents with
a diameter of 3 mm and smaller ones was not statistically significant. Yet, the lumen visualization of the smaller stents
was impaired by a halo effect. The XCD kernel showed more constant attenuation values throughout the different
stent diameters than the other reconstruction kernels.
Conclusions: The 256-MSCT provides a good lumen visualization of coronary stents with a diameter >3 mm. The
assessment of stents with a diameter of 3 mm seems feasible but has to be validated in further studies. The clinical
evaluation of smaller stents cannot be recommended so far. The XCD kernel showed the best lumen visualization and
should therefore be applied in addition to the standard cardiac reconstruction kernels when assessing coronary artery
stents using 256-MSCT.
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In a previous study we could show that the 256-multislice
computed tomography (MSCT) yields promising results
for the visualization of coronary artery stents using a tech-
nical approach [1]. Therefore, we provide an update on
this trial employing a clinically applicable technique.
Currently, percutaneous coronary intervention (PCI)
and stent placement are the leading coronary revascular-
ization therapies in patients with coronary artery disease
(CAD). Approximately 492 000 patients underwent PCI* Correspondence: florian.andre@med.uni-heidelberg.de
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reproduction in any medium, provided the orprocedures in the US in 2010 [2]. The clinical use
of drug eluting stents (DES) instead of bare metal stents
(BMS) reduces the rates of in-stent restenosis (ISR)
from about 20-30% to less than 10% [3,4]. But despite
the increasing amount of DES coronary interventions,
ISR and stent thrombosis are still a major limitation of
PCI, leading to an increased morbidity and mortality in
patients with coronary stents [5]. Moreover, a considerable
number of these patients have to undergo conventional
coronary angiography (CA) to exclude ISR. In addition to
bearing the risks of an invasive procedure, CA is linked to
considerable health care costs. Hence, a non-invasive
alternative may be of great clinical interest as well as of
socio-economic benefit.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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using MSCT is a non-invasive imaging modality for the
reliable diagnosis and assessment of CAD yielding a
sensitivity of 97% - 99% and a specificity of 88% - 89%
[6,7]. Yet, the evaluation of coronary artery stents is
challenging due to artifacts like beam hardening and
partial volume effects caused by the metal of the stent
struts and sporadically by the stents’ radio-opaque
markers. First attempts to visualize the lumen of coron-
ary artery stents using CT were made about 20 years
ago using electron beam CT without reaching an image
quality that was sufficient for analysis [8]. Since then,
the MSCT technology has developed tremendously and
new scanner generations with 4, 16 and 40 slices have
been assessed for ISR detection [9,10]. With the intro-
duction of the 64-MSCT the reliable visualization of ISR
seemed to be achievable [11]. Yet, several reviews came
to the conclusion that the diagnostic performance of the
64-MSCT was not sufficient in patients with implanted
coronary artery stents [12-14].
The introduction of the latest CT scanner generations
including dual source CT (DSCT) with high temporal
resolution on the one hand and single-source MSCT
with wide z-axis coverage of 256 or 320 slices on the
other hand arose the hope for reliable stent lumen
assessment. In addition, previous studies showed that
stent-dedicated, sharper reconstruction kernels were
able to reduce stent artifacts and improve stent lumen
visualization [1,15,16].
In the first study using the 256-MSCT for the assess-
ment of coronary artery stents, our research group got
promising results [1]. We applied a full width at half
maximum algorithm to measure the extent of the im-
paired in-stent lumen visualization objectively. Yet, this
technical approach is associated with a high effort and
is, therefore, impractical for a daily-base clinical use.
Furthermore, the obtained results might reflect technical
values rather than visual assessment as performed in
clinical routine – hence the need for an assessment of the
stent lumen visualization capability of the 256-MSCT
using a clinically applicable approach. In this study, we
sought to investigate coronary stent visualization and
in-stent lumen assessment using various kernels in a
state of the art 256-MSCT by employing a visual analysis
technique.
Methods
We included 51 stents of different diameters, materials,
strut designs and manufacturers in this study. A sum-
mary is provided in Table 1.
The stents were assorted into three groups according
to their diameters: group A: stents < 3 mm, group B:
stents = 3 mm, group C: stents > 3 mm. The stents were
expanded at the nominal pressure of their respectivedelivery system into a vessel phantom, which was made
of plastic tubes with a wall thickness of 0.5 mm. Stents
of group A and B were placed in tubes with an inner
diameter of 3 mm, stents of group C in tubes with an
inner diameter of 4 mm. The tubes were filled with con-
trast agent and saline (Ultravist 370, Bayer HealthCare,
Leverkusen, Germany) providing a radio-density of ap-
proximately 250 HU. Afterwards, the tubes were closed
at both ends and placed into a plastic basin. This was
filled with an oil-iodine solution attaining a radiodensity
of approximately −70 HU according to the epicardial fat
tissue. The basin was placed into the gantry, thus
aligning the tubes in a parallel manner to the scanner´s
z-axis.
Imaging was performed on a 256-slice CT scanner
(Brilliance iCT, Philips Healthcare, Cleveland, OH, USA)
applying the following parameters: helical mode, colli-
mation = 2 × 128 × 0.625 mm, tube voltage = 120 kV,
tube current-time product = 800 mAseff, pitch = 0.18, tube
rotation time = 270 ms, field of view = 180 mm.
All images were reconstructed at 75% of an artificial
ECG-signal with a heart rate of 60 bpm using a matrix
of 512 × 512. Four different convolution kernels were
applied: a) Xres detailed stent (XCD), b) cardiac sharp
(CC), c) cardiac detailed stent (CD) and Xres standard
(XCB). While XCB is the standard kernel for the re-
construction of coronary arteries, XCD and CD are
dedicated kernels for the visualization of stents.
The analysis was carried out on a dedicated CT post-
processing workstation (Extended Brilliance Workspace V
3.5.3.1020, Philips Healthcare, Cleveland, OH, USA) with
a window center of 300 HU and a width of 1200 HU.Artificial lumen narrowing
Artificial lumen narrowing (ALN) was defined as the
difference between the nominal stent diameter and the
one measured visually using the electronic diameter pro-
vided by the workstation’s software. Measurements were
performed in axial orientation in a proximal, middle and
distal part of the stent and a mean value was calculated.Stent and tube lumen attenuation
As the measured radio-density inside the stent lumen
can be influenced by artifacts like beam hardening or
partial volume effects, we measured two values: stent
lumen attenuation (SLA) and tube lumen attenuation
(TLA). The quantification was carried out in a longitu-
dinal view by a region-of-interest (ROI) technique. SLA
was assessed by placing the largest possible ROI inside
the lumen of the deployed stent omitting strut artifacts.
For TLA two ROIs were positioned inside the tube
lumen outside both sides of the stent and a weighted
mean value was calculated.
Table 1 List of coronary artery stents
Manufacturer Name ∅ (mm) L (mm) Material ST (mm) Drug ALN (%)
Medtronic Endeavor Resolute 2.25 12 CoCr 0.091 Zotarolimus 45
Medtronic Endeavor Resolute 2.25 8 CoCr 0.091 Zotarolimus 44
Medtronic Micro-Driver 2.25 24 Cobalt alloy 0.091 41
Abbott Vascular Multi-Link Mini Vision 2.50 28 Cobalt alloy 0.081 41
Abbott Vascular Multi-Link Mini Vision 2.50 18 Cobalt alloy 0.081 40
Biotronik PRO-Kinetic 2.50 22 CoCr + SiC coating 0.060 53
Cordis Cypher Select Plus 2.50 18 316 L 0.140 Sirolimus 43
Medtronic Endeavor Resolute 2.50 12 CoCr 0.091 Zotarolimus 36
Medtronic Endeavor Resolute 2.50 24 CoCr 0.091 Zotarolimus 32
Medtronic Micro-Driver 2.50 24 Cobalt alloy 0.091 36
Terumo Tsunami Gold 2.50 20 316 L 0.080 43
Abbott Vascular Multi-Link Vision 2.75 8 CoCr 0.081 36
Medtronic Endeavor Resolute 2.75 8 CoCr 0.091 Zotarolimus 33
Medtronic Endeavor Resolute 2.75 30 CoCr 0.091 Zotarolimus 35
Medtronic Endeavor Sprint 2.75 24 CoCr 0.091 Zotarolimus 33
Medtronic Micro-Driver 2.75 18 Cobalt alloy 0.091 33
Medtronic Micro-Driver 2.75 24 Cobalt alloy 0.091 36
B. Braun Coroflex Blue 3.00 19 CoCr 0.065 41
B. Braun Coroflex Please 3.00 19 316 L 0.120 Paclitaxel 40
Biotronik PRO-Kinetic 3.00 30 CoCr + SiC coating 0.060 50
Boston Scientific Liberté 3.00 20 316 L 0.097 38
Boston Scientific Liberté 3.00 16 316 L 0.097 44
Boston Scientific Taxus Liberté 3.00 16 316 L 0.097 Paclitaxel 39
Boston Scientific Taxus Liberté 3.00 20 316 L 0.097 Paclitaxel 40
Cordis Presillion 3.00 17 CoCr 0.073 38
Cordis Presillion 3.00 12 CoCr 0.073 39
Medtronic Driver 3.00 12 Cobalt alloy 0.091 40
Medtronic Endeavor Resolute 3.00 12 CoCr 0.091 Zotarolimus 44
MSM Experimental* 3.00 16 316 L + Tantal coating 0.080 38
Terumo Tsunami Gold 3.00 18 316 L 0.080 42
Terumo Tsunami Gold 3.00 18 316 L 0.080 39
Translumina Yukon* 3.00 18 316 L 0.115 41
Translumina Yukon Choice* 3.00 18 316 L 0.097 40
Translumina Yukon Choice CC* 3.00 18 316 L 0.100 41
Abbott Vascular Multi-Link Vision 3.50 28 CoCr 0.081 25
Abbott Vascular Multi-Link Vision 3.50 12 CoCr 0.081 33
Biotronik PRO-Kinetic 3.50 20 CoCr + SiC coating 0.080 27
Cordis Cypher Select Plus 3.50 13 316 L 0.140 Sirolimus 32
Cordis Cypher Select Plus 3.50 18 316 L 0.140 Sirolimus 30
Medtronic Driver 3.50 9 Cobalt alloy 0.091 30
Medtronic Endeavor 3.50 9 CoCr 0.091 30
Medtronic Endeavor Resolute 3.50 24 CoCr 0.091 Zotarolimus 22
Medtronic Endeavor Resolute 3.50 9 CoCr 0.091 Zotarolimus 25
Medtronic Endeavor Sprint 3.50 24 CoCr 0.091 Zotarolimus 21
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Table 1 List of coronary artery stents (Continued)
Medtronic Endeavor Sprint 3.50 18 CoCr 0.091 Zotarolimus 25
Terumo Tsunami Gold 3.50 10 316 L 0.080 33
Terumo Tsunami Gold 3.50 18 316 L 0.080 30
Biotronik PRO-Kinetic 4.00 20 CoCr + SiC coating 0.080 29
Medtronic Driver 4.00 9 Cobalt alloy 0.091 29
Medtronic Driver 4.00 24 Cobalt alloy 0.091 33
Medtronic Driver 4.00 12 Cobalt alloy 0.091 31
*stent without a delivery system which was expanded using a balloon catheter.
List of different manufacturers, stent types, dimensions, materials and drugs of the 51 applied coronary artery stents. In addition, the ALN values of every stent
using the XCD kernel are provided.





ALN: artificial lumen narrowing (given as percentage of the nominal lumen diameter).
Table 2 Artificial lumen narrowing
Group XCD CC CD XCB
All 36(21/53) ± 7 45(26/79) ± 11 45(29/71) ± 10 42(26/73) ± 10
A 39(32/53) ± 6 52(37/79) ± 12 51(39/71) ± 9 48(37/73) ± 10
B 41(38/58) ± 3 50(44/54) ± 3 49(36/57) ± 6 46(40/53) ± 4
C 29(21/33) ± 4 35(26/44) ± 5 34(29/46) ± 5 32(26/42) ± 5
Artificial lumen narrowing values are given as mean (minimum/maximum) ±
standard deviation in percent of the nominal lumen diameter.
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Attenuation was defined as the difference between stent
lumen attenuation and tube lumen attenuation:
Attenuation ¼ SLA−TLA
We defined image noise as the mean value of the
standard deviations of three axial ROIs which were
positioned outside the tube lumen in the oily fluid.
Statistical methods
Data were analyzed with a statistical software (MedCalc
Statistical Software, V 11.4.1.0, MedCalc bvba, Belgium).
Normal distribution was assessed applying the Kolmogorov-
Smirnov test. We used an analysis of variance for the
comparison of the artificial lumen narrowing values of
different groups.
As some of the attenuation values were not distributed
normally, we applied the non-parametric Friedman test
for the comparison of the different kernels. For the com-
parison of different stent size groups regarding the
attenuation, the Mann–Whitney test was used as the
stents of different groups were not paired.
Statistical significance was defined at p < 0.05 after




The mean ALN values for the different reconstruction
kernels and groups are listed in Table 2. In addition, a
list of the ALN values of all stents as measured applying
the XCD kernel is provided in Table 1.
Collectively, the XCD kernel showed markedly lower
ALN values than all other kernels (p < 0.001). Also the
XCB kernel was significantly different to all other
reconstruction algorithms (p < 0.001). Between the CCand CD kernel no significant differences were observed
(p > 0.05).
ALN values for group A versus group B stents were
not significantly different (p > 0.05) for all kernels in
contrast to group C stents which showed a significantly
lower value (p < 0.001).
Figure 1 shows an example of a stent reconstructed
with various reconstruction kernels. Figure 2 demon-
strates exemplarily the effect of the stent diameter by
showing three different sizes of two stent types.
Halo effect
Especially the XCD kernel yielded comparatively low
ALN values for the small group A stents (see Figure 3).
However, the apparently well-definable stent boundaries
were visually hampered by what we labeled as ‘halo
effect’: an artificially increased in-stent lumen image
signal in the vicinity of the strut-lumen interface that
decreases gradually towards the stent lumen center. An
example of the halo effect is given in Figure 4.
Attenuation
The median attenuation values with the respective
interquartile range (IQR) of all kernels and groups are
summarized in Table 3.
Collectively, the CC kernel (18 IQR 183 HU) showed
significantly the lowest attenuation values followed by
Figure 1 Differences of reconstruction kernels. Reconstructions
of the same stent applying the four different kernels. (B. Braun Coroflex
Please, nominal diameter 3.0 mm, length 19 mm).
Figure 2 Effect of different stent diameter. Reconstructions of
three different sizes of the same stent type (top: Biotronik PRO-Kinetic,
bottom: Medtronic Endeavor Resolute). Diameter is given in mm. Zoom
factors differ between the stent types.
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between CD and XCD (43 IQR 34 HU) yielded no
significance, the XCB method showed a significantly
higher value (128 IQR 122 HU) than all other kernels.
Consequently, we performed an analysis of the differ-
ent stent size groups.
For group A stents, the discrepancy between all
kernels was significant with the XCD kernel providing
values closer to the optimum of zero than the other ones.
In group B, XCD showed no significant differences to
CD whereas all other differences including those to XCB
were significant. CC showed the best attenuation values
followed by XCD.
In group C, only the difference between XCD and
XCB was not significant with CD providing the attenu-
ation values closest to the optimum of zero.
Whereas the values for XCD remained quite constant
and only declined about 13 HU from group A to C, the
other groups showed notably higher drops up to 240
HU for the CC kernel (see Figure 5). The CC and the
CD kernel even showed negative values.
Noise
As noise was measured independently from the stent
diameter a sub-categorization into different groups was
not reasonable. The soft XCB kernel showed significantlylower values than all other kernels (15.8 ± 1.9 HU). Of the
remaining kernels, the CD kernel had the highest values
(34.9 ± 4.6 HU), whereas values for the XCD (21.1 ± 2.9
HU) and CC (19.9 ± 2.2 HU) kernels were comparable.
Yet the differences between all kernels were statistically
significant (all p < 0.001).
Discussion
In a state of the art 256-MSCT scanner four different
reconstruction kernels were employed to scan 51
Figure 3 Artificial lumen narrowing. Comparison of the ALN values of different stent groups applying the four reconstruction kernels.
Figure 4 Example of the halo effect. The ALN for this stent was manually measured as 45%. However, the lumen visualization was considerably
impaired by the halo effect (Medtronic Endeavor Resolute, nominal diameter 2.25 mm, length 12 mm).
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Table 3 Attenuation
Group XCD CC CD XCB
All 43(22/174)IQR34 18(−177/392)IQR183 40(−78/254)IQR96 128(6/396)IQR122
A 55(22/174)IQR55 127(14/392)IQR186 78(14/254)IQR34 189(116/396)IQR158
B 41(27/125)IQR48 36(−2/151)IQR65 48(9/153)IQR56 131(87/265)IQR59
C 42(22/116)IQR17 −113(−177/-18)IQR35 −29(−78/33)IQR29 49(6/163)IQR33
Attenuation values are given as median (minimum/maximum) interquartile range in HU.
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ies could show that the quantification of atherosclerotic
coronary lumen narrowing as well as the assessment of
plaque is feasible with this scanner generation [17].
However, to date there is only scarce data regarding
the potential of the 256-MSCT for the visualization of
the coronary stent lumen [1,18,19]. In contrast to our
first technical oriented studies, we applied a clinically
applicable approach.
The applied XCB kernel is the standard algorithm for
the assessment of coronary arteries in Philips CT
scanners. For the reconstruction of coronary stents the
CD and XCD kernel are provided by the manufacturer.
Although both kernels have similar reconstruction
characteristics, the XCD features a reduced image noise.
In previous studies concerning stent visualization the
B46f kernel has been recommended for the 64-MSCT
and DSCT from Siemens [15,16] and the Q04 kernel for
Toshiba’s 64-MSCT [20].
Overall and in all stent groups, the Philips XCD kernel
showed lower ALN values than the other three kernels.
The edge-enhancing characteristic of the XCD’s reconstruc-
tion method provided sufficiently visible strut margins, soFigure 5 Attenuation. Attenuation values as provided by the different rec
the CC and CD kernels become negative.that the electronic caliper could be positioned precisely in
most measurements. Consequently, the ALN standard
deviations of the XCD kernel were smaller compared to
the other three kernels. A similar superiority of the XCD
kernel became evident with respect to the attenuation.
The measured attenuation values applying the XCD kernel
were consistent across the stent size groups whereas the
attenuation for the CC and CD kernels declined from
highly positive values in small stents to even negative
measurements in larger stents. The phenomenon of
radiodensity values being lower in the stent than in the
tube lumen has been described before [1,15,21]. One may
speculate that the sharpening algorithms of these kernels
could be responsible for this effect. However, the diagnos-
tic value and interpretation of negative attenuation values
within the stent lumen is unclear and needs further inves-
tigation. Although the CD kernel showed attenuation
values closer to the optimum of zero in group C stents, it
was accompanied by considerable higher noise and ALN.
As the XCB kernel is softer than the others, it
provided significantly lower noise values. Yet, the noise
difference between the XCD and the XCB kernels was
only about 5 HU and therefore negligible.onstruction kernels. Note that with increasing stent size the values of
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reliable ALN and attenuation values at the cost of a little
higher noise. Our first conclusion therefore is that we
recommend the application of the XCD kernel in
addition to the routine XCB kernel when examining a
patient with a coronary artery stent.
We investigated various coronary artery stents of
different sizes, designs, materials and manufacturers. As
most of the coronary stents used in clinical routine are
either made of 316 L stainless steel or cobalt chrome,
the stent size and architecture is, in a majority of cases,
a more important factor for the quality of stent lumen
visualization than the material.
At first glance, the ALN values for group A and B
stents seemed to be astonishingly low with most values
being <50% using the XCD kernel. However, the visibil-
ity of their lumina was impaired by a phenomenon we
introduced as ‘halo effect’ (Figure 4). This phenomenon
resembles the so-called blooming artifact but unlike this
it is rather characterized by altered attenuation values
inside the stent than by an exaggerated thickness of the
stent struts as described for blooming [22,23]. The halo
effect seemed to be more pronounced in smaller stents,
especially when reconstructed with harder kernels.
Although the struts were clearly visible the assessability
of the adjacent lumen was impaired. As the voxel signals
at the interface between tube lumen and stent struts
seemed to be artificially smeared, atherosclerotic pro-
cesses like ISR could potentially be missed or misinter-
preted. Clinically, the halo effect could therefore often
lead to false diagnoses. Therefore, we advise against the
employment of coronary CT for the exclusion of ISR in
stents <3 mm due to the halo effect.
In agreement with our findings, in a lately published
meta-analysis on 64-MSCT, Carrabba et al. stated that
the rate of uninterpretable stent lumina tended to be
more pronounced for stent diameters <3 mm [24]. Like-
wise, in a recent review about the diagnostic accuracy of
64-MSCT for the detection of ISR, Sun et al. concluded
that stent lumen evaluation should be restricted to larger
stents (>3 mm) [11]. Since these measurements were
generated using 64-MSCT, state of the art scanner gen-
erations such as DSCT or 256-MSCT have encouraged
the expectation that ISR in smaller stents could accur-
ately be detected or excluded. And indeed, Pugliese
et al., in a clinical DSCT study in which stent lumen
assessment of different sizes was investigated, showed that
the negative predictive value was 100% for stents ≥3 mm
and 90% for stents ≤2.75 mm [25]. Although stent diame-
ters ≤2.75 mm lead to frequently false positive results, the
authors drew the conclusion that DSCT coronary angiog-
raphy could reliably rule out ISR irrespective of the
stent size due to its high negative predictive value. In
another clinical DSCT study all stent lumen with adiameter >3 mm were assessable, whereas only 81% of
stents with a caliber of 3 mm could be evaluated [26].
To date, there is only one clinical pilot study assessing
the diagnostic capability of the 256-MSCT for ISR detec-
tion in 28 patients [18]. In this study, Oda et al. attained
a sensitivity and specificity of 100% and 55% by com-
bining the CD kernel with an iterative reconstruction
algorithm leading to positive and negative predictive
values of 40% and 100%. Yet, the authors state the limi-
tation that the diagnostic performance of the 256-MSCT
in different stent sizes and types was not evaluated. In
our in-vitro study, all stents with a diameter of 3 mm,
that were reconstructed with the XCD kernel, showed
an ALN that did not exceed 50%, which is sufficient to
exclude a significant luminal stenosis >50%. Compared
to group A stents (<3 mm), the extent of the halo effect
was clearly less pronounced in group B (3 mm). There-
fore, clinical in-vivo stent assessment might be possible
for group B stents using the XCD kernel. However,
future in-vitro and in-vivo studies are required to exam-
ine the possibility of stent lumen visualization for stents
with a diameter of 3 mm in 256-MSCT.
Group C stents (>3 mm) revealed significantly lower
ALN values and showed a negligible extent of the
halo effect. These findings are in line with previously
published literature and leads us to recommend 256-
MSCT for the stent lumen assessment of coronary
stents with a lumen diameter larger than 3.0 mm
[1,11,21,26,27].
Study limitations
Although the phantom was designed to mimic in-vivo
conditions and has been used in a previous study,
several limitations have to be considered.
First, all stents were scanned in an orientation parallel
to the scanner’s z-axis. Previous studies have indicated
that the quality of stent visualization may depend on the
stent and scanner angulations [28,29].
Second, since a static phantom with an artificial con-
tinuous heart rate of 60 bpm was used, cardiac and
respiratory movements could not be simulated. There-
fore, high temporal resolution techniques of the 256-
MSCT like fast rotation time and wide z-axis coverage
were not regarded.
Third, the scan parameters in this study were chosen
similar to the protocols for clinical routine. We did not
evaluate the potential of advanced dose-saving algo-
rithms for stent visualization. This may be an objective
of further studies.
Fourth, the window settings were chosen in accord-
ance with previous studies [1,30]. Yet, these settings
indeed influence the visual measurement of the stent
lumen diameter, as the visible strut thickness may vary
at different settings.
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phantom studies concerning coronary stent visualization,
the results are not fully comparable.
Conclusions
With the 256-MSCT, the assessment of stent lumina
larger than 3 mm is clinically possible if stent-dedicated
kernels are applied. The XCD reconstruction kernel
proved to be superior for lumen visualization independ-
ently from the stent caliber. The stent lumen visualization
of stents with a diameter of 3 mm seems to be feasible but
has to be validated in further studies.
Additional investigations are needed to assess the
visualization of stents with a lumen diameter smaller
than 3 mm. Further improvements in stent designs and
materials as well as in CT spatial resolution and recon-
struction methods could help accomplish the assessment
of coronary stents using CT as part of the clinical routine.
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